iatroX logo
brainstormaskiatroXuk q-bankus q-bankknowledge centreblog
Knowledge Centre / Candidiasis (Vulvovaginal)

Candidiasis (Vulvovaginal)

Management of vaginal thrush.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Women's Health

Clinical Guidelines

British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis
National
CKS: Acute infection - Candida - female genital
National
CKS: Candida - female genital
National
ACOG Practice Bulletin Number 215: Vaginitis in Nonpregnant Patients
Local
British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2020)
Local
Candidiasis (vulvovaginal) treatment guidelines - Melbourne Sexual Health Centre
Local
Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
Local

Recent iatroX Q&As

  • What are the recommended first-line treatments for vulvovaginal candidiasis in non-pregnant women?Updated: 8/16/2025
  • How can I differentiate between vulvovaginal candidiasis and other causes of vulvovaginal symptoms?Updated: 8/16/2025
  • What are the guidelines for managing recurrent vulvovaginal candidiasis in women?Updated: 8/16/2025
  • When should I consider referring a patient with vulvovaginal candidiasis for specialist evaluation?Updated: 8/16/2025
  • What lifestyle and preventive measures can I advise patients to reduce the risk of vulvovaginal candidiasis?Updated: 8/16/2025
askiatroX
privacytermshow it workscpdinsightsfaqabout
UKCA Mark

iatroX is a UKCA-marked, MHRA-registered medical device.

Download on the App StoreGet it on Google Play